first evaluated POMT in ten previously untreated patients with invasive large adenomas, demonstrating that preoperative somatostatin receptor ligands (SRLs, e.g., SMS 201-995) markedly reduced GH and IGF-1 levels and resolved or diminished parasellar and cavernous sinus invasion (17). This evidence concerns the gene GH1 and adenoma.